Navigation Links
Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin,Emerging Growth Conference

SOUTH SAN FRANCISCO, Calif., July 03, 2007 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. today announced that Eric Bjerkholt, Sunesis' Senior Vice President, Corporate Development and Finance, will present a company update at the C. E. Unterberg, Towbin Emerging Growth Conference on July 12, 2007 at 9:00 a.m. Eastern Time in New York, NY.

Interested parties may access the webcast of the presentation by visiting the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks until July 26, 2007.

Option Award Disclosure

The Compensation Committee of the company's Board of Directors approved an employment commencement grant to Mr. Michael Coors, Director, Quality Assurance, of a non-qualified stock option to purchase 25,000 shares of Sunesis common stock, effective June 29, 2007. These option awards were granted without shareholder approval pursuant to Nasdaq Marketplace Rule 4350 (i)(1)(A)(iv) and with the following material terms: (a) an exercise price equal to the fair market value of the company's common stock on the grant date, (b) a term of ten years, and (c) a vesting schedule providing that the option is exercisable as to one-quarter of the total grant on the first anniversary of their hire, and one-forty-eighth of the total grant each month thereafter until the grant is fully vested.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-h
'"/>




Page: 1 2

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
2. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
3. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
4. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
5. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... Collaborative R&D Terms & Agreements ... https://www.reportbuyer.com/product/2276220/Collaborative-RD-Terms--Agreements-in-Pharma-Biotech-and-Diagnostics.html The Collaborative R&D ... Diagnostics report provides comprehensive understanding and unprecedented ... agreements entered into by the worlds leading ...
(Date:8/27/2014)... FAIRFAX, Va. , Aug. 27, 2014 ... in the legs due to buildup of fatty plaque ... expected in the aging patient population and in incidences ... Radiology offers its Lower Extremity Arterial RevascularizatioN ... Ariz. Endovascular specialists and interested residents and ...
(Date:8/27/2014)...  Decision Resources Group finds that physicians surveyed ... gastroenterology, endocrinology and nephrology) expect the robustness and ... been assessed in to be the strongest influencers ... Other key findings from the ... of Biosimilars Across Physician Specialties : ...
Breaking Medicine Technology:Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2
... CT Colonography Trial Raise Questions for,Patients, OAK ... CT Colonography Trial, published in the September 18 ... improvements in the technology,s,ability to diagnose intermediate- to ... testing is not as effective in diagnosing small ...
... September 18th New England Journal of,Medicine, Each year ... these deaths could be prevented by regular screening. Yet, ... be screened for the disease are,not being tested - ... with current screening exams., However, results of an ...
Cached Medicine Technology:ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 3ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 4ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 5MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy 2
(Date:8/27/2014)... 28, 2014 Spine Guide has built ... of information on spinal health. Now, the e-health site ... people suffering from back pain symptoms. Spine Guide specializes ... surgery, and lumbar spine surgery. , Some of the ... or stabbing pain, pain radiating down the leg, inability ...
(Date:8/27/2014)... The National League for Nursing is pleased to ... became the inaugural director of the NLN/Chamberlain College ... of Nursing Education , effective August 11. The center ... for Transformative Excellence, established with the League’s historic move ... Under Dr. Dennis’s leadership, the NLN/Chamberlain Center will expand ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer ... celebrity bodycon dresses . The company has rich experience ... trendy items in stock and ready to ship: celebrity ... sleeve sweater dresses and so forth. All of them ... , “We are proud to announce the new collection ...
(Date:8/27/2014)... Philadelphia, PA. Inc. magazine ranked ... 500 list, an exclusive ranking of the nation’s fastest-growing ... look at the most important segment of the economy ... early exposure as members of the Inc. 500 list ... , “Some of world’s greatest companies have had their ...
(Date:8/27/2014)... 2014 All Canada Goose Parkas ... go from classic to modern. With unique detailing such as ... them is a step up in opulence. Recently, the company ... Parkas for 2014. , True enough, the new ... great discounts (up to 28% off) on all these brand ...
Breaking Medicine News(10 mins):Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:Inc Magazine Unveils 33rd Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2
... Anti-fungal and anti-bacterial additives in house paint are present ... the city of Lausanne, says a study to be ... Union (AGU) conference in San Francisco. Chemicals engineered to ... in order to prevent molding and plant growth. Washed ...
... By Alan Mozes HealthDay Reporter , FRIDAY, Dec. ... is just one more form of entertainment. But for Katie ... true cause for celebration. "It was absolute redemption," said ... Michael, 16-year-old son Dylan, and 14-year-old son Dusty -- who ...
... GREENVILLE, S.C. From their fourth-floor state-of-the-art laboratory in ... University bioengineering scientists and students help keep the feet ... new facility, which opens this week, houses one of ... hip, knee and other artificial joints that were removed ...
... certain form of inherited hearing loss have increased ... study by Professor Thomas Jentsch of the Leibniz-Institut ... Medicine (MDC) Berlin-Buch and Professor Gary Lewin (MDC), ... and Nijmegen, the Netherlands. The research findings, which ...
... , FRIDAY, Dec. 9 (HealthDay News) -- Premature infants ... than full-term babies, new research shows. However, the ... Candida fungus, are also more dangerous, researchers from Duke University ... [full-term] infants, whereas in premature infants, they seem to be ...
... were common and long-lasting during the first two ... a new study from Johns Hopkins University School ... factor for impaired physical function. "Early identification ... as a potential,intervention to improve long-term outcomes in ...
Cached Medicine News:Health News:Model shows how façade pollutants make it into the environment 2Health News:Broadway Strikes an Autism-Friendly Chord 2Health News:Broadway Strikes an Autism-Friendly Chord 3Health News:Broadway Strikes an Autism-Friendly Chord 4Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 2Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 3Health News:People with DFNA2 hearing loss show increased touch sensitivity 2Health News:People with DFNA2 hearing loss show increased touch sensitivity 3Health News:Preemies Infected With More Dangerous Types of Bacteria: Study 2Health News:Depressive symptoms and impaired physical function are frequent and long-lasting after ALI 2
Inquire...
Inquire...
Inquire...
One Piece: Premier Pouches - Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
Medicine Products: